» Articles » PMID: 8048191

Prostatic Cryotherapy: Ultrasonographic and Pathologic Correlation in the Canine Model

Overview
Journal Urology
Specialty Urology
Date 1994 Aug 1
PMID 8048191
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Cryotherapy of the prostate has been reintroduced clinically due to improved ultrasound guidance and cryotechnology. The purpose of this canine feasibility study was to assess the accuracy of transrectal ultrasound (TRUS) in monitoring iceball progression with histologic correlation.

Methods: Six mongrel dogs received cryotherapy to the entire prostate and were observed for selected periods of 1 day to 12 weeks with TRUS follow-up. Some technical limitations of the canine model prohibited complete comparison with techniques currently used in humans.

Results: TRUS monitoring of posterior iceball progression proved to be highly accurate and correlated with subtotal necrosis of the rectal wall, sparing the mucosal layer with millimeter accuracy. The prostate was completely necrotic in three of six dogs. Scattered residual glands remained at the distal apex in one dog and in the posterolateral periphery of a larger-volume prostate. Cryotherapy missed the prostate in one dog due to pelvic hematoma formation and poor TRUS visualization. Without adequate urethral warming, central sloughing was noted in chronic animals. Histologic examination demonstrated hemorrhagic infarction with subsequent ingrowth of transitional epithelium from the urethra producing re-epithelialization of glandular spaces along the residual collagenous architecture.

Conclusions: Accurate TRUS monitoring of prostate cryotherapy allows thorough yet careful extension of the iceball through the posterior aspect of the prostate. Unique histologic changes may account for the unremarkable TRUS appearance following cryotherapy, as well as some of the benign, "atypical" glands seen on follow-up biopsies in humans.

Citing Articles

Relative Effects of Various Factors on Ice Ball Formation and Ablation Zone Size During Ultrasound-Guided Percutaneous Cryoneurolysis: A Laboratory Investigation to Inform Clinical Practice and Future Research.

Said E, Marsh-Armstrong B, Fischer S, Suresh P, Swisher M, Trescot A Pain Ther. 2023; 12(3):771-783.

PMID: 37000371 PMC: 10199980. DOI: 10.1007/s40122-023-00497-y.


Percutaneous Image-Guided Ablation of Lung Tumors.

Alzubaidi S, Liou H, Saini G, Segaran N, Kriegshauser J, Naidu S J Clin Med. 2021; 10(24).

PMID: 34945082 PMC: 8707332. DOI: 10.3390/jcm10245783.


Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art.

Paez-Carpio A, Gomez F, Isus Olive G, Paredes P, Baetens T, Carrero E Insights Imaging. 2021; 12(1):57.

PMID: 33914187 PMC: 8085189. DOI: 10.1186/s13244-021-00997-5.


Lung Ablation: Indications and Techniques.

Tafti B, Genshaft S, Suh R, Abtin F Semin Intervent Radiol. 2019; 36(3):163-175.

PMID: 31435124 PMC: 6699876. DOI: 10.1055/s-0039-1693981.


Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Jones G, Kehrer J, Kahn J, Koneru B, Narayan R, Thomas T Clin Lung Cancer. 2015; 16(6):413-30.

PMID: 26027433 PMC: 4609584. DOI: 10.1016/j.cllc.2015.04.001.